Researcher

Yun Chen

Zhejiang Cancer Hospital

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 10, 2026 · JOURNAL ARTICLE

ROS-autocatalytic nanoplatform interfering astrocyte-cancer crosstalk and enhancing glioblastoma therapy

Nature Communications

Preclinical proof-of-concept study demonstrating a novel nanoplatform mechanism in cell and animal models, without human efficacy data or direct comparison to standard therapy.

Hypothesis-GeneratingZonghua Tian Nanoparticle-based Drug Delivery Hongrui Fan

Study details

DesignPreclinical mechanistic study (cell culture…

InterventionGS@DFP nanoplatform co-loaded with S-Gboxin…

SEP 9, 2026 · JOURNAL ARTICLE

Deep and durable response to re-challenge with platinum-based therapy in a platinum-relapsed small cell lung cancer patient following Olvi-Vec oncolytic immunotherapy: a case report

Frontiers in Oncology

A single-case report from an ongoing Phase Ib trial describing one patient's response; while the outcome is noteworthy, case reports lack comparison groups and generalizability to support clinical practice change.

PreliminaryYong A. Yu Zhi-Quan Qin Animal Virus Infections Studies

Reported

Target lesion size reduction84.6%

Progression-free survival16.7 months